Inicio・Lista de Acciones・Erasca Inc

Erasca Inc

Cerrado

18.32 0.49

Comprar Vender

Resumen

Variación precio

24h

Actual

Mínimo

18.11

Máximo

18.48

Métricas clave
By Trading Economics
Ingresos	-154M -183M
BPA	-0.6
Empleados	103
EBITDA	-151M -183M

Recomendaciones
By TipRanks
Recomendaciones	Compra Fuerte
Estimación a 12 Meses	+20.7% upside

Dividendos
By Acuity
Próximas Ganancias	10 ago 2026

Estadísticas de Mercado
By TradingEconomics
Capitalización Mercado	2.9B 6.2B
Apertura anterior	17.83
Cierre anterior	18.32

Erasca Inc Gráfico

Resultados pasados no son un indicador fiable de resultados futuros.

Noticias Relacionadas

7 ago 2026, 23:56 UTC

Correlated Moves

American Water Works shows little change in after-market trading, remaining near the upper end of its one-month range amid reduced rate hike concerns.

7 ago 2026, 23:56 UTC

Lululemon Athletica shares are higher in after-market hours, continuing a trend of four consecutive sessions above the 20-day moving average. No specific news was identified.

7 ago 2026, 23:56 UTC

Crown Holdings Inc shares are lower in after-market hours, continuing a downward trend amid decreased expectations for immediate Federal Reserve interest rate hikes.

7 ago 2026, 23:56 UTC

Arcosa Inc shares declined slightly in after-market trading, remaining near the lower end of their one-month trading range. No specific news was identified.

7 ago 2026, 23:56 UTC

No specific news for Synchrony Financial as after-market trading remains roughly flat. The stock is above its 20-day moving average and near its one-month high.

7 ago 2026, 23:56 UTC

Correlated Moves

Insteel Industries Inc. shares remained roughly flat in after-market hours, reflecting broader market dynamics and the impact of Federal Reserve interest rate considerations.

7 ago 2026, 23:56 UTC

Atkore Inc. shares declined after-market, retracing from an initial peak post-close. The stock remains near the upper end of its one-month range.

7 ago 2026, 23:56 UTC

Academy Sports and Outdoors Inc. shares are roughly flat in after-market trading, with no specific news driving the minimal movement since Friday's close.

7 ago 2026, 23:56 UTC

Correlated Moves

Snap-On Inc shares are higher in after-market trading, reflecting strong interest and aligning with broader market trends. The stock remains above its 20-day moving average.

7 ago 2026, 23:56 UTC

Correlated Moves

Waters Corp shares declined in after-market trading, following a broader trend influenced by recent economic data and a weak jobs report.

7 ago 2026, 23:56 UTC

Cerus Corp shares are higher in after-market trading, recovering from earlier declines amid shifting expectations for Federal Reserve interest rate hikes.

7 ago 2026, 23:56 UTC

Marriott International shares are higher in after-market trading, though no specific news was identified to explain the movement. The stock remains below its 20-day moving average.

7 ago 2026, 23:56 UTC

Ensign Group Inc. shares traded roughly flat in after-market hours, reflecting minor adjustments amid Federal Reserve interest rate outlook concerns following a weak jobs report.

7 ago 2026, 23:56 UTC

Brady Corp shares are higher in after-market trading, reflecting a modest gain since Friday's close and positioning above its 20-day moving average.

7 ago 2026, 23:56 UTC

American States Water Co. shares traded roughly flat after hours amid broader market concerns about the Federal Reserve's interest rate policies following a weak jobs report.

7 ago 2026, 23:56 UTC

Axos Financial Inc. shares were roughly flat in after-market trading amid broader market concerns over potential Federal Reserve interest rate hikes.

7 ago 2026, 23:56 UTC

Toro Co shares traded with little change during after-market hours, fluctuating within a narrow range. The stock remains above its 20-day moving average.

7 ago 2026, 23:56 UTC

NAPCO Security Technologies traded roughly flat in after-market hours, remaining significantly above its 20-day moving average after seven consecutive sessions of higher closes.

7 ago 2026, 23:56 UTC

Bio Rad Laboratories Inc. shares declined in after-market trading, reflecting routine fluctuations. The stock remains above its 20-day moving average.

7 ago 2026, 23:56 UTC

ABM Industries shares showed routine trading activity after market hours, fluctuating slightly around Friday's close and remaining near the upper end of its one-month range.

7 ago 2026, 23:56 UTC

Equifax Inc. shares were roughly flat during after-market hours, trading near the upper end of their one-month range. No specific news was identified.

7 ago 2026, 23:56 UTC

Correlated Moves

Steven Madden Ltd traded roughly flat in after-market hours, reflecting broader market trends amid tempered expectations for Federal Reserve interest rate hikes.

7 ago 2026, 23:56 UTC

Prestige Consumer Healthcare Inc. shares traded roughly flat after-market hours, following six consecutive higher daily closes and remaining above its 20-day moving average.

7 ago 2026, 23:56 UTC

Shares of LTC Properties Inc. are higher in after-market hours, influenced by decreased expectations for immediate interest rate hikes following a weak jobs report.

7 ago 2026, 23:56 UTC

Correlated Moves

News Corp shares gained slightly in after-market trading, supported by a favorable market environment following a weak jobs report and decreased rate hike expectations.

7 ago 2026, 23:56 UTC

PJT Partners Inc shares are higher in after-market trading, despite no specific news. A weaker jobs report may be influencing investor sentiment.

7 ago 2026, 23:56 UTC

UDR Inc shares declined in after-market trading, reflecting broader market concerns over potential Federal Reserve interest rate hikes amid weak job data.

7 ago 2026, 23:56 UTC

Correlated Moves

Whirlpool Corp shares rose in after-market trading, reflecting broader market trends and decreased expectations for immediate interest rate hikes following a weak jobs report.

7 ago 2026, 23:56 UTC

Universal Health Services Inc. shares are lower in after-market trading, reflecting routine performance amid recent macroeconomic data and a weak jobs report.

7 ago 2026, 23:56 UTC

Correlated Moves

Albany International Corp shares are higher in after-market trading, supported by broader market dynamics and decreased interest rate hike expectations following a weak jobs report.

Comparación entre iguales

Cambio de precio

Erasca Inc previsión

Precio Objetivo

By TipRanks

20.7% repunte

Estimación a 12 Meses

Media 22.22 USD 20.7%

Máximo 30 USD

Mínimo 18 USD

De acuerdo con 9 analistas de Wall Street que ofrecen objetivos de precios a 12 meses para Erasca Inc Dist en los últimos 3 meses.

Consenso

By TipRanks

Compra Fuerte

9 ratings

Comprar

Mantener

Vender

De acuerdo con 9 analistas que ofrecen calificaciones bursátiles a para Erasca Inc Dist en los últimos 3 meses.

Finanzas

Gastos de venta y administración

Gastos operativos

Beneficio antes de impuestos

Ventas

Coste de ventas

Beneficio bruto de ventas

Gasto por intereses de deuda

EBITDA

Beneficio operativo

Acerca de Erasca Inc

Erasca, Inc., a clinical-stage precision oncology company, focuses on discovering, developing, and commercializing therapies for patients with RAS/MAPK pathway-driven cancers. The company's lead product is naporafenib which is in phase 1b trial for patients with RAS Q16X solid tumors and plans to initiate a pivotal Phase 3 trial for patients with NRASm melanoma. It also develops ERAS-007, an oral inhibitor of ERK1/2 for the treatment of non-small cell lung and colorectal cancer, and advanced gastrointestinal malignancies; and ERAS-601, an oral SHP2 inhibitor for patients with advanced or metastatic solid tumors. In addition, it is developing ERAS-801, a central nervous system-penetrant EGFR inhibitor which is in phase 1 clinical trials for the treatment of patients with recurrent glioblastoma multiforme. The company entered into license agreement with Novartis to develop, manufacture, use, and commercialize naporafenib; Katmai Pharmaceuticals, Inc. to develop, manufacture, use, and commercialize ERAS-801 and certain other related compounds; and NiKang Therapeutics, Inc. to develop and commercialize ERAS-601 and certain other related compounds. Erasca, Inc. was incorporated in 2018 and is headquartered in San Diego, California.